Last reviewed · How we verify

NCT05149534

rTMS-augmented Written Exposure Therapy for PTSD

Recruiting now NA Last updated 12 January 2026
What this trial tests

NA trial testing Written Exposure Therapy in Post Traumatic Stress Disorder in 98 participants. Currently enrolling.

Timeline
3 January 2022
Primary endpoint
29 January 2027
29 January 2027

Quick facts

Lead sponsorVA Office of Research and Development
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment98
Start date3 January 2022
Primary completion29 January 2027
Estimated completion29 January 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

VA Office of Research and Development — full company profile →

Who can join

Adults 18 to 60, any sex, with Post Traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Post-traumatic stress disorder (PTSD) is prevalent and represents a high healthcare burden among Veterans. Repetitive transcranial magnetic stimulation (rTMS) is a brain-based therapy that may be effective for treating PTSD. The theorized mechanism of rTMS is enhancement of emotional flexibility via the dorsolateral prefrontal cortex node of the brain's cognitive control network. Given this mechanism of action, adding rTMS to an evidence-based psychotherapy (EBP) for PTSD may enhance treatment effects. Written exposure therapy (WET) is a brief EBP for PTSD found to reduce attrition compared to lengthier first line treatments. In this study, the investigators will determine if active rTMS added to WET compared with sham rTMS added to WET results in improved PTSD outcomes. The investigators will also determine if emotional flexibility is a mechanism of symptom improvement. This work will improve upon PTSD intervention and inform the mechanism of treatment effectiveness for Veterans suffering from PTSD.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Repetitive transcranial magnetic stimulation for post-traumatic stress disorder in adults.
    Brown R, Cherian K, Jones K, Wickham R, et al · · 2024 · cited 6× · PMID 39092744 · DOI 10.1002/14651858.cd015040.pub2
  2. Interventional Psychiatry and Emerging Treatments for Posttraumatic Stress Disorder (PTSD): A Systematic Review.
    Janssen-Aguilar R, Meshkat S, Al-Shamali HF, Perivolaris A, et al · · 2025 · cited 2× · PMID 40879152 · DOI 10.5152/pcp.2025.241027

Verify or expand the search:

Other trials of Written Exposure Therapy

Trials testing the same drug.

Other recruiting trials for Post Traumatic Stress Disorder

Currently open trials in the same condition.

Other VA Office of Research and Development trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05149534.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing